Global Parkinson's Disease Treatment Market Growth Drivers Research 2022

The Parkinson’s disease treatment market is expected to grow from USD 4.24 billion in 2017 to USD 5,694.1 million in 2022 to grow at a CAGR of 6.1%. Factors such as the increasing aging population worldwide and government funding for research on Parkinson’s disease are driving this market. However, the availability of alternative treatments is expected to restrain this market.

Click   Here   for   Complete   Report   on   Parkinson’s  Disease  Treatment  Market   spread  across   113 Pages, Profiling 13 Companies and Supported with 66 Tables and 33 Figures at http://www.rnrmarketresearch.com/parkinsons-disease-treatment-market-by-drug-class-carbidopa-levodopa-dopamine-receptor-agonists-mao-inhibitors-distribution-channel-hospital-online-retail-pharmacies-patient-care-setting-hospitals-clin-st-to-2022-market-report.html .

Parkinson’s disease is the second most common neurodegenerative disorder and the most common movement disorder. Characteristics of Parkinson’s disease are progressive loss of muscle control, which leads to trembling of the limbs and head while at rest, stiffness, slowness, and impaired balance.

Introduction

1 Objective of the Study

2 Market Definition

3 Markets Covered

4 Years Considered in the Study

5 Currency

6 Limitations

7 Stakeholders

On the basis of drug class, the Parkinson’s disease treatment market is classified into carbidopa/levodopa, dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to register the highest growth rate during the forecast period. The growth of this market segment is mainly driven by its potency and wide adoption in the treatment of Parkinson’s disease.

Click Here for Sample Papers of  Parkinson’s  Disease  Treatment  Market  with Top Trends and Company Profile at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1228151 .

By distribution channel type, the Parkinson’s disease treatment market is segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. The online pharmacies segment is expected to register highest CAGR during the forecast period. Advantages such as 24/7 ordering, home delivery, and discounts on medicines are the driving factors for this segment.

Parkinson’s Disease Treatment Market, By Drug Class

1 Introduction

2 Carbidopa/Levodopa

3 Dopamine Receptor Agonists

4 Mao Inhibitors

5 Comt Inhibitors

6 Anticholinergics

7 Other Drugs

Click Now for More Details on “Parkinson’s Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) – Global Forecast to 2022”report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1228151 .

Geographically, the Parkinson’s disease treatment market is dominated by Europe, followed by North America, Asia, and the Rest of the World (RoW). Europe is expected to command the largest share of the Parkinson’s disease treatment market. The large share of this segment can be attributed to the growing aging population, presence of key players, and increasing healthcare expenditure in the region. The Asian region is estimated to grow at the fastest rate during the forecast period.

The primary interviews conducted for this report can be categorized as follows:

By Company Type – Tier 1 – 70% and Tier 2 – 30%

By Designation – C-level – 62%, Director Level – 21%, Others – 17%

By Region – North America –50%, Europe – 20%, Asia – 30%

List of Tables

1 Global Parkinson’s Disease Treatment Market Summary
2 Ageing Population, By Region, 2015 vs 2030
3 Parkinson’s Disease Treatment Market: List of Pipeline Drugs
4 Parkinson’s Disease Treatment Market, By Drug Class, 2016–2022 (USD Million)
5 Carbidopa/Levodopa Market, By Region, 2015–2022 (USD Million)
6 North America: Carbidopa/Levodopa Market, By Country, 2015–2022 (USD Million)

Request for call back:

[email protected]  / Call +1 888 391 5441

For further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.